Literature DB >> 1666298

Phase II study of sulofenur (LY186641) in untreated patients with extensive small cell lung cancer.

F A Shepherd, R MacCormick, E A Eisenhauer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1666298     DOI: 10.1093/oxfordjournals.annonc.a057866

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  1 in total

1.  A phase I study of sulofenur in refractory pediatric malignant solid tumors.

Authors:  C B Pratt; L C Bowman; N Marina; A Pappo; L Avery; X Luo; W H Meyer
Journal:  Invest New Drugs       Date:  1995       Impact factor: 3.850

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.